Goodwin a conseillé Azulis Capital dans le cadre de la cession de Novepan. Le Management de Novepan était conseillé par Piotraut Giné Avocats. Sagard était conseillé...
Sagard’s Acquisition of Novepan
Shopify’s $100 Million Investment in Klaviyo
Osler, Hoskin & Harcourt LLP advised Shopify on the matter while Goodwin represented Klaviyo. On August 2, 2022, Shopify announced it has made a $100 million...
Lacerta Therapeutics’ Capsid Licensing and Research Collaboration Agreement with Prevail Therapeutics.
Goodwin Procter advised Lacerta Therapeutics on the deal. Lacerta Therapeutics announced its AAV capsid licensing and research collaboration agreement with Prevail Therapeutics. As a part of...
Thoma Bravo’s AUD $1.055 Billion Acquisition of Nearmap
Goodwin Procter advised Thoma Bravo on the deal. Thoma Bravo, a leading software investment firm, announced its definitive agreement to acquire 100% of the shares in...
Medipost Co.’s Agreement with OmniaBio
Goodwin Procter advised Medipost Co. on the deal. Medipost Co. announced its strategic agreement with OmniaBio, Inc., a subsidiary of the Centre for Commercialization of Regenerative Medicine...
Vespene Energy’s $4.3 Million Financing Round
Goodwin Procter advised Polychain Capital on the deal. Polychain Capital announced its lead investment in Vespene Energy’s $4.3 million financing round. Polychain Capital is a premier investor...
Company and global PE fund’s Acquisition of Flusso
Goodwin Procter advised Flusso on the deal. Flow sensing company Flusso announced their joint sale to a company and a global private equity fund focused on investing...
Q32 Bio’s Collaboration and Option Agreement with Horizon Therapeutics Ireland DAC
Goodwin Procter advised Q32 Bio on the deal. Q32 Bio announced its collaboration and option agreement with Horizon Therapeutics Ireland DAC under which both companies will collaborate...
Carlyle and Abingworth’s $170 Million Non-dilutive Financing of Opthea
Goodwin Procter and Debevoise & Plimpton advised Carlyle on the deal, while Cooley and Gilbert+Tobin advised Opthea. Global investment firm Carlyle and its life sciences franchise...
Insempra’s Investment into Solena Materials
Goodwin Procter advised Insempra on the deal. Insempra announced its strategic investment into Solena Materials Ltd (“Solena”) a synthetic biology company. Solena, a spin-out from Imperial College...
KVH Industries’ Asset Purchase Agreement with EMCORE Corporation
Goodwin Procter advised KVH Industries on the deal while Pillsbury advised EMCORE Corporation. KVH Industries, Inc. (NASDAQ: KVHI) announced its asset purchase agreement with EMCORE Corporation....
908 Devices’ Acquisition of TRACE Analytics GmbH
Goodwin Procter advised 908 Devices on the deal. 08 Devices (Nasdaq: MASS) announced its acquisition of TRACE Analytics GmbH. With the acquisition of TRACE Analytics GmbH, 908...